OmniAb (OABI) Free Cash Flow (2021 - 2026)
OmniAb's (OABI) quarterly Free Cash Flow came in at -$5.1 million in Q1 2026, up 68.4% year-on-year from -$3.0 million in Q1 2025, and up 24.74% on a QoQ basis from -$6.8 million in Q4 2025.
OmniAb (OABI) Free Cash Flow (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Free Cash Flow data on file, last reported at -$5.1 million in Q1 2026.
- On a quarterly basis, Free Cash Flow rose 68.4% year-over-year to -$5.1 million in Q1 2026; TTM through Mar 2026 was -$26.0 million, a 35.15% increase from a year earlier, with the FY2025 full-year figure at -$37.0 million, up 10.88% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$5.1 million, up from -$6.8 million in the prior quarter.
- Over the last five years, Free Cash Flow for OABI reached as high as $27.8 million in Q1 2023 and fell as low as -$17.5 million in Q1 2024.
- Historically, Free Cash Flow has averaged -$5.1 million across 5 years, with a median of -$6.3 million in 2024.
- Across the five-year window, Free Cash Flow jumped 216.31% in 2022 and slumped 644.57% in 2023, its largest moves.
- Year by year, Free Cash Flow stood at -$9.7 million in 2022, then gained by 0.33% to -$9.7 million in 2023, then soared by 34.63% to -$6.3 million in 2024, then fell by 6.97% to -$6.8 million in 2025, then increased by 24.74% to -$5.1 million in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were -$5.1 million in Q1 2026, -$6.8 million in Q4 2025, and -$8.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | OmniAb | 261.62 Mn | 212.55 Mn | 14.41 Mn | -5.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.08 Mn |
| Mar 31, 2026 | -5.08 Mn |
| Dec 31, 2025 | -6.75 Mn |
| Dec 31, 2025 | -6.75 Mn |
| Sep 30, 2025 | -8.88 Mn |
| Sep 30, 2025 | -8.88 Mn |
| Jun 30, 2025 | -5.31 Mn |
| Jun 30, 2025 | -5.31 Mn |
| Mar 31, 2025 | -16.08 Mn |
| Mar 31, 2025 | -16.08 Mn |
| Dec 31, 2024 | -6.31 Mn |
| Dec 31, 2024 | -6.31 Mn |
| Sep 30, 2024 | -4.34 Mn |
| Sep 30, 2024 | -4.34 Mn |
| Jun 30, 2024 | -13.40 Mn |
| Jun 30, 2024 | -13.40 Mn |
| Mar 31, 2024 | -17.50 Mn |
| Mar 31, 2024 | -17.50 Mn |
| Dec 31, 2023 | -9.65 Mn |
| Dec 31, 2023 | -9.65 Mn |